Azura Ophthalmics Raises US$20 Million for Registration Studies for Treatment of Leading Cause of Dry Eye Disease
Press Release Lead clinical asset AZR-MD-001 for Meibomian gland dysfunction to advance through registration study Meibomian gland dysfunction is the leading cause of Dry Eye Disease, a condition known to affect more than 30 million adults in the United States alone Financing also will support development of pipeline of new chemical entities in pre-clinical through […]